What Happened?
New York, NY-based Volastra-Therapeutics Appointed Samuel Bakhoum as Co Founder
About the Company
Volastra aims to extend the lives of patients with cancer by leveraging unique insights into chromosomal instability. Moving away from primary tumor models to target the site of metastasis in the toughest-to-treat solid tumors, we are altering the treatment paradigm for metastatic cancers.
About the Person
Samuel Bakhoum is Co Founder at Volastra Therapeutics. Previously, Samuel held various senior HR leadership roles in the industry.
Info Source
News
Short Profile